Intratracheal budesonide-poly(lactide-co-glycolide) microparticles reduce oxidative stress, VEGF expression, and vascular leakage in a benzo(a)pyrene-fed mouse model

Journal of Pharmacy and Pharmacology

Volumn 57, Issue 7, 2005, Pages 851-860

  Bandi, Nagesh ^a   Ayalasomayajula, Surya P ^a   Dhanda, Devender S ^a   Iwakawa, Jun ^a   Cheng, Pi Wan ^a   Kompella, Uday B ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BENZO[A]PYRENE; BUDESONIDE; BUDESONIDE POLYGLACTIN; GLUTATHIONE; MALONALDEHYDE; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG MECHANISM; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LUNG LAVAGE; LUNG PARENCHYMA; LUNG TUMOR; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PARTICLE SIZE;

ANIMALS; BENZO(A)PYRENE; BRONCHODILATOR AGENTS; BUDESONIDE; CARCINOGENS; DELAYED-ACTION PREPARATIONS; FEMALE; INJECTIONS, INTRAMUSCULAR; LUNG NEOPLASMS; MICE; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; PARTICLE SIZE; POLYGLACTIN 910; TRACHEA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 21044431602     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357056334     Document Type: Article

References (45)

1. Ayalasomayajula, S. P., Kompella, U. B. (2002) Induction of vascular endothelial growth factor by 4-hydroxynonenal and its prevention by glutathione precursors in retinal pigment epithelial cells. Eur. J. Pharmacol. 449: 213-220
2. Ayalasomayajula, S. P., Kompella, U. B. (2003) Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model. Eur. J. Pharmacol. 458: 283-289
3. Bandi, N., Kompella, U. B. (2001) Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells. Eur. J. Pharmacol. 425: 109-116
4. Bunn, P. A., Soriano, A., Johnson, G., Heasley, L. (2000) New therapeutic strategies for lung cancer: biology and molecular biology come of age. Chest 117: 163S-168S
5. Chanoine, F., Grenot, C., Heidmann, P., Junien, J. L. (1991) Pharmacokinetics of butixocort 21-propionate, budesonide, and beclomethasone dipropionate in the rat after intratracheal, intravenous, and oral treatments. Drug Metab. Dispos. 19: 546-553
6. Clissold, S. P., Heel, R. C. (1984) Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis. Drugs 28: 485-518
7. Cox, G., Jones, J. L., Walker, R.A., Steward, W. P., O'Byrne, K. J. (2000) Angiogenesis and non-small cell lung cancer. Lung Cancer 27: 81-100
8. Eskens, F. A. (2004) Angiogenesis inhibitors in clinical development; where are we now and where are we going? Br. J. Cancer 90: 1-7
9. 3 particles. Toxicol. Lett. 121: 107-117
10. Ghussen, F., Kruger, I. (1989) Technical aspects of isolation extremity perfusion: experimental studies and clinical experience. J. Invest. Surg. 2: 487-496
11. Giatromanolaki, A. (2001) Prognostic role of angiogenesis in non-small cell lung cancer. Anticancer Res. 21: 4373-4382
12. Giovino, G. A. (2002) Epidemiology of tobacco use in the United States. Oncogene 21: 7326-7340
13. Gray, D. L., Warshawsky, D., Xue, W., Nines, R., Wang, Y., Yao, R., Stoner, G. D. (2001) The effects of a binary mixture of benzo(a)pyrene and 7H-dibenzo(c,g)carbazole on lung tumors and K-ras oncogene mutations in strain A/J mice. Exp. Lung Res. 27: 245-253
14. Herbst, R. S., Fidler, I. J. (2000) Angiogenesis and lung cancer: potential for therapy. Clin. Cancer Res. 6: 4604-4606
15. Jain, R. A. (2000) The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 21: 2475-2490
16. Janero, D. R. (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic. Biol. Med. 9: 515-540
17. Jonat, C., Rahmsdorf, H. J., Park, K. K., Cato, A. C., Gebel, S., Ponta, H., Herrlich, P. (1990) Antitumor promotion and anti-inflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62: 1189-1204
18. Karmpaliotis, D., Kosmidou, I., Ingenito, E. P., Hong, K., Malhotra, A., Sunday, M. E., Haley, K. J. (2002) Angiogenic growth factors in the pathophysiology of a murine model of acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 283: L585-595
19. Kemeny, N., Huang, Y., Cohen, A. M., Shi, W., Conti, J. A., Brennan, M. F., Bertino, J. R., Turnbull, A. D., Sullivan, D., Stockman, J., Blumgart, L. H., Fong, Y. (1999) Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N. Engl. J. Med. 341: 2039-2048
20. Kerbel, R. S., Viloria-Petit, A., Okada, F., Rak, J. (1998) Establishing a link between oncogenes and tumor angiogenesis. Mol. Med. 4: 286-295
21. Kompella, U. B., Bandi, N., Ayalasomayajula, S. P. (2001) Poly(lactic acid) nanoparticles for sustained release of budesonide. Drug Del. Technol. 1(1): 28-34
22. Kompella, U. B., Bandi, N., Ayalasomayajula, S. P. (2003) Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Invest. Ophthalmol. Vis. Sci. 44: 1192-1201
23. Konduri, K. S., Nandedkar, S., Duzgunes, N., Suzara, V., Artwohl, J., Bunte, R., Gangadharam, P. R. (2003) Efficacy of liposomal budesonide in experimental asthma. J. Allergy Clin. Immunol. 111: 321-327
24. Konishi, T., Huang, C. L., Adachi, M., Taki, T., Inufusa, H., Kodama, K., Kohno, N., Miyake, M. (2000) The K-ras gene regulates vascular endothelial growth factor gene expression in non-small cell lung cancers. Int. J. Oncol. 16: 501-511
25. Koukourakis, M. I., Giatromanolaki, A., Thorpe, P. E., Brekken, R. A., Sivridis, E., Kakolyris, S., Georgoulias, V., Gatter, K. C., Harris, A. L. (2000) Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer. Cancer Res. 60: 3088-3095
26. Kraft, W. K., Steiger, B., Beussink, D., Quiring, J. N., Fitzgerald, N., Greenberg, H. E., Waldman, S. A. (2004) The pharmacokinetics of nebulized nanocrystal budesonide suspension in healthy volunteers. J. Clin. Pharmacol. 44: 67-72
27. Lai, Y. L., Mehta, R. C., Thacker, A. A., Yoo, S. D., McNamara, P. J., DeLuca, P. P. (1993) Sustained bronchodilation with isoproterenol poly(glycolide-co-lactide) microspheres. Pharm. Res. 10: 119-125
28. Li, D. W., Spector, A. (1997) Hydrogen peroxide-induced expression of the proto-oncogenes, c-jun, c-fos and c-myc in rabbit lens epithelial cells. Mol. Cell Biochem. 173: 59-69
29. Marchetti, P., Urien, S., Cappellini, G. A., Ronzino, G., Ficorella, C. (2002) Weekly administration of paclitaxel: theoretical and clinical basis. Crit. Rev. Oncol. Hematol. 44 (Suppl.): S3-13
30. Markman, M. (1996) Intraperitoneal therapy of ovarian cancer. Oncologist 1: 18-21
31. Markman, M. (1999) Intraperitoneal chemotherapy in the management of colon cancer. Semin. Oncol. 26: 536-539
32. Maulik, N., Das, D. K. (2002) Redox signaling in vascular angiogenesis. Free Radic. Biol. Med. 33: 1047-1060
33. Nelson, H. H., Kelsey, K. T. (2002) The molecular epidemiology of asbestos and tobacco in lung cancer. Oncogene 21: 7284-7288
34. Pereira, M. A., Li, Y., Gunning, W. T., Kramer, P. M., Al-Yaqoub, F., Lubet, R. A., Steele, V. E., Szabo, E., Tao, L. (2002) Prevention of mouse lung tumors by budesonide and its modulation of biomarkers. Carcinogenesis 23: 1185-1192
35. Ruddell, A., Mezquita, P., Brandvold, K. A., Fair, A., Iritani, B. M. (2003) B lymphocyte-specific c-Myc expression stimulates early and functional expansion of the vasculature and lymphatics during lymphomagenesis. Am. J. Pathol. 163: 2233-2245
36. Singh, S. V., Benson, P. J., Hu, X., Pal, A., Xia, H., Srivastava, S. K., Awasthi, S., Zaren, H. A., Orchard, J. L., Awasthi, Y. C. (1998) Gender-related differences in susceptibility of A/J mouse to benzo[a]pyrene-induced pulmonary and forestomach tumorigenesis. Cancer Lett. 128: 197-204
37. Srivastava, S. K., Xia, H., Pal, A., Hu, X., Guo, J., Singh, S. V. (2000) Potentiation of benzo[a]pyrene-induced pulmonary and forestomach tumorigenesis in mice by D, L-buthionine-S, R-sulfoximine-mediated tissue glutathione depletion. Cancer Lett. 153: 35-39
38. Stoner, G. D., Shimkin, M. B. (1991) Lung tumors in strain A mice as a bioassay for carcinogenicity. In: Milman, H. A., Weisburger, E. K. (eds) Handbook of carcinogen testing. Noyes Publications, Park Ridge, NJ, pp 179-214
39. Suarez, S., O'Hara, P., Kazantseva, M., Newcomer, C. E., Hopfer, R., McMurray, D. N., Hickey, A. J. (2001) Airways delivery of rifampicin microparticles for the treatment of tuberculosis. J. Antimicrob. Chemother. 48: 431-434
40. Tao, L., Li, Y., Wang, W., Kramer, P. M., Gunning, W. T., Lubet, R. A., Steele, V. E., Pereira, M. A. (2002) Effect of budesonide on the methylation and mRNA expression of the insulin-like growth factor 2 and c-myc genes in mouse lung tumors. Mol. Carcinog. 35: 93-102
41. Wattenberg, L. W., Estensen, R. D. (1997) Studies of chemopreventive effects of budesonide on benzo[a]pyrene-induced neoplasia of the lung of female A/J mice. Carcinogenesis 18: 2015-2017
42. Wattenberg, L. W., Wiedmann, T. S., Estensen, R. D., Zimmerman, C. L., Steele, V. E., Kelloff, G. J. (1997) Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res. 57: 5489-5492
43. Wattenberg, L. W., Wiedmann, T. S., Estensen, R. D., Zimmerman, C. L., Galbraith, A. R., Steele, V. E., Kelloff, G. J. (2000) Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol. Carcinogenesis 21: 179-182
44. Yanagihara, K., Seki, M., Cheng, P. W. (2001) Lipopolysaccharide induces mucus cell metaplasia in mouse lung. Am. J. Respir. Cell Mol. Biol. 24: 66-73
45. Yuan, J. W., Krieger, J. A., Maples, K. R., Born, J. L., Burchiel, S. W. (1994) Polycyclic aromatic hydrocarbons decrease intracellular glutathione levels in the A20.1 murine B cell lymphoma. Fundam. Appl. Toxicol. 23: 336-341